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The Balanced Budget Act: Potential
implications for the practice of vascular
surgery
Sean P. Roddy, MD, Thomas F. O’Donnell, Jr, MD, Amy L. Wilson, BA,
James M. Estes, MD, and William C. Mackey, MD, Boston, Mass
Purpose: Previous study results have shown a favorable impact on stroke rate with an
increasing hospital volume of carotid endarterectomies (CEAs). This is not only the
most frequently performed peripheral vascular procedure in the United States but also
perhaps the most widely dispersed procedure relative to hospital type. Medical centers
have adopted various strategies to lower the cost of hospitalization by reducing the
length of stay (LOS), the major component of hospital cost. By 2002, the Balanced
Budget Act is projected to reduce Medicare provider payments to academic medical
centers (AMCs) by 15.5%, a reduction that is twice that for minor or nonteaching hos-
pitals. We assessed the relationships between hospital costs, CEA volume, and stroke-
mortality rates in AMCs and non-AMCs in Massachusetts.
Methods: With patient level data from the Massachusetts Division of Health Care
Finance and Policy and with hospital cost and charge reports from the Health Care
Financing Administration, HealthShare Technology provided data for all the patients
discharged from a Massachusetts hospital who underwent CEA (n = 10,211) during
the fiscal years 1995, 1996, and 1997, including cost, LOS, and disposition. The out-
comes were further defined with in-hospital stroke and mortality rates. Five high vol-
ume AMCs (HVAMCs) were compared with all other nonacademic hospitals, which
were further subdivided by annual volume into high volume non-AMCs (≥50 cases),
medium volume non-AMCs (24-49 cases), and low volume non-AMCs (12-23 cases).
Statistical analysis was performed with analysis of variance to compare the means of all
the cost and LOS data, and χ2 test was used for comparison of incidence (significance
assumed for P ≤.05).
Results: Hospital costs were comparable among the four hospital types during individ-
ual years and averaged $6200, but HVAMCs were significantly more expensive overall,
with a mean cost of $7882. The only centers to decrease their costs during the years eval-
uated were the HVAMCs, from $8706 to $6784. Length of stay did not differ among
the groups in any year or overall, with a mean of 3.8 days, but did decrease between
years at HVAMCs from 3.9 to 2.5 days. The combined stroke-mortality rates were sig-
nificantly less at the HVAMCs (0.9%) than at either the high volume non-AMCs (1.9%)
or the medium volume non-AMCs (2.5%). There was no significance in the analysis
results of all the data within the low volume non-AMCs.
Conclusion: Patients in HVAMCs have the best outcomes after CEA. Despite the achieve-
ment of significant efficiencies, AMCs have a small cushion to reduce further either LOS
or resources to maintain a competitive cost position and to compensate for the fixed
expenses of academic medicine. The Balanced Budget Act raises an equity concern for
AMCs because it differentially affects the centers with the best outcomes. The financial
implication of this may be a direct incentive for procedures to be done in centers with
less optimal outcomes. (J Vasc Surg 2000;31:227-36.)
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In this age of cost containment, the practice of vas-
cular surgery is under increased pressure to reduce
resource use. Carotid endarterectomy (CEA) is the
most frequently performed peripheral vascular proce-
dure in the United States, with more than 130,000
cases completed annually.1 It may also be the most
widely distributed procedure relative to hospital type.
Carotid endarterectomy has a further advantage in
that the indications and outcomes for this operation
have been extensively scrutinized in the United States
and abroad with randomized prospective studies.2,3
Previous study results have shown that an increasing
hospital volume of CEAs, just as in other procedures
(eg, coronary artery bypass grafting surgery and total
hip replacement), has a favorable impact, with reduc-
tion of adverse outcomes.4-10 Medical centers have
adopted various strategies to lower the cost of hospi-
talization by reducing length of stay (LOS), the puta-
tive major component of hospital cost, and by mini-
mizing resource use, all of which might affect out-
come.11 Although the Balanced Budget Act (BBA) of
1997 has had multiple impacts on hospital incomes, it
has had a disproportionate impact on academic med-
ical centers (AMCs). The Massachusetts Hospital
Association projects that the BBA will reduce Medi-
care Provider Payment System payments 15.5% to
AMCs by the year 2002. This reduction in reimburse-
ment to AMCs is twice that to minor or nonteaching
hospitals, which affects Medicare graduate medical
education (GME) reimbursements and, in particular,
indirect medical education. The Association of
American Medical Colleges published estimates in
their May 1999 Fact Sheet stating that profit margins
will drop in 2002 at major teaching hospitals to less
than 0.25%, whereas profit margins at nonteaching
and minor teaching centers will remain at more than
4%. We assessed the relationships among hospital
costs, CEA volume, and combined stroke-mortality
rates in AMCs and non-AMCs in Massachusetts.
METHODS
HealthShare Technology maintains a database
that contains a host of variables related to hospital
discharges in the state of Massachusetts. Data on
individual patients, including charges, were obtained
from the Massachusetts Division of Health Care
Finance and Policy, and hospital cost and charge
data were provided by the Health Care Financing
Administration. This publically available database
was polled for all patients who underwent CEA dur-
ing the fiscal years (FYs) 1995 (FY95), 1996
(FY96), and 1997 (FY97). This review was under-
taken with the search of the tightly defined proce-
dure code 38.12 (endarterectomy, vessels of the
head and neck, extracranial) according to the
International Classification of Disease, 9th Revision,
Clinical Modification (ICD-9-CM).12 Any hospital
admission in which a CEA was performed was
included, regardless of whether the patients were
admitted directly to a surgical service or transferred
from a medical service. Combined CEA/coronary
artery bypass grafting procedures were excluded
(with ICD-9-CM procedure codes 35.2, 35.3, and
36.1). Age, cost, LOS, intensive care unit (ICU)
LOS, and disposition data were obtained. The out-
comes were further defined with in-hospital stroke
and in-hospital mortality rates.
The cost data were determined with the ratio of
cost to charges (RCC) approach, which requires two
steps.13 First, RCCs are developed for each depart-
ment in each hospital with charge, total cost (after
indirect allocation), and direct cost (before alloca-
tion) information from the specific hospital’s
Medicare Cost Report. Second, the hospital’s
departmental RCCs are applied against the depart-
ment charges for each hospital patient to derive a
total and direct cost amount for that patient by
department. These cost figures are totaled in every
department to arrive at the true total cost and direct
cost for each patient. This methodology can be inac-
curate in the determination of the cost of a single
item in a given department because it assumes a
standard markup across the board. However, this
gains strength when several departments are ana-
lyzed, which allows the overestimates to cancel out
the underestimates in the overall hospital cost.
The method for the determination of in-hospi-
tal stroke rates differed for the FY95 cohort versus
the FY96 and FY97 cohorts. The ICD-9-CM
diagnostic code 997.02 (iatrogenic cerebrovascu-
lar accident, postoperative) was created in 1996 by
the National Center for Health Statistics and was
used for the analysis of FY96 and FY97 data.12
The previous code equivalent used (for years 1995
and earlier) on the basis of the ICD-9-CM classifi-
cation system included patients who had both
code 997.9 (surgical complications, body system
neck) and one of the following codes: 430, sub-
arachnoid hemorrhage; 431, intracerebral hemor-
rhage; 432, intracranial hemorrhage not exclud-
ing/not otherwise specified; 433, precerebral
occlusion; 434, cerebral artery occlusion; and 436,
cerebrovascular accident. This is also the equiva-
lent that the National Center for Health Statistics
recommends and uses in the preparation of na-
tional CEA outcome reports. We used this algo-
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rithm at our institution for each of the years sur-
veyed, and the stroke-death rate was correct.
For the purposes of statistical analysis, the med-
ical centers were first divided into a category of
either academic or nonacademic. The definition of
an AMC in this paper relied on the presence of two
criteria: (1) the center was a medical school’s princi-
pal teaching hospital(s), and (2) the center possessed
an accredited vascular fellowship.
The centers then were subdivided by the volume
of CEAs performed for each FY. Most papers that
review annual volume data for CEAs refer to 50
cases as high volume. We decided to accept this
quota, halving it as the definition for medium vol-
ume. We then halved it again to come up with a low-
volume number. The centers with less than 12 cases
annually were excluded from any analysis. The final
requirements were then set at high (≥50 cases),
medium (24-49 cases), and low (12-23 cases).
We generated four groups on the basis of these
definitions. The first group included all high vol-
ume AMCs (HVAMC) in one metropolitan city,
namely Boston. Boston Medical Center (Boston
University) was not a high volume center in any
year surveyed. The University of Massachusetts was
a high volume center, but is not located in Boston.
Therefore, both of these AMCs were excluded from
analysis. This single city group was compared with
all other non-AMCs in the state listed as high vol-
ume non-AMCs (HVNAMC), medium volume
non-AMCs (MVNAMC), and low volume non-
AMCs (LVNAMC).
Statistical analysis was performed independently
by the Center for Clinical Research at New England
Medical Center (NEMC). The data were evaluated
with analysis of variance to compare the means of all
the cost and LOS data, and a χ2 test was used in
comparison of incidence. Subgroup analysis was
achieved with Bonferonni adjusted P values from
pairwise comparisons of means (≤.05).
RESULTS
Procedure volume. During the 3-year period,
there were 10,211 CEAs performed in the
Commonwealth of Massachusetts, with a mean of
60.3 hospitals (range, 59-62 hospitals). The yearly
totals were relatively constant, with 3388 proce-
dures in FY95, 3568 in FY96, and 3255 in FY97.
The average patient age was 70.5 years, with a
55.2% male predominance. Indication (eg, asymp-
tomatic versus symptomatic) could not be obtained
from this data source. Table I summarizes the total
number of CEAs by year and grouping. It also pre-
sents the number of medical centers in each of the
categories. These were fairly constant with no sig-
nificant differences per year. The average number of
CEAs performed per year at HVAMCs was 192, at
HVNAMCs was 76, at MVNAMCs was 36, and at
LVNAMCs was 19. This obviously falls into the cat-
egories outlined previously, but the number at the
HVAMCs was significantly higher than that at the
HVNAMCs (P <.000001). Table II summarizes
cost, demographic, and outcome data in a tabular
format. Each of the groupings is listed by the results
of the FY and are then combined. From this synop-
sis, we have found several important relationships.
Hospital costs. We first compared hospital cost
data both with and without direct medical expense
(DME). Although the hospital costs with DME
were comparable among the four hospital types in
FY95 (P = .10), FY96 (P = .41), and FY97 (P = .40)
individually, the HVAMCs were significantly more
expensive than the other three medical centers over-
all (P = .03). Interestingly, there was a significant
decrease sequentially that averaged $961 per year for
HVAMCs during the 3 years (P = .03). The total
cost without DME did not differ among individual
years or overall, and the HVAMCs lowered total cost
without DME significantly by $845 per year (P =
.0095).
Length of stay. At HVAMCs, ICU LOS was
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Table I. Number of carotids (number of institutions)
FY95 FY96 FY97 Total % of total
Totals 3388 (59) 3568 (60) 3255 (62) 10,211 100
HVAMC 967 (5) 989 (5) 927 (5) 2883 28.2
HVNAMC 1546 (19) 1771 (23) 1309 (18) 4626 45.3
MVNAMC 561 (17) 463 (13) 669 (18) 1693 16.6
LVNAMC 136 (7) 122 (7) 180 (10) 438 4.2
Excluded* 178 (11) 223 (12) 170 (11) 571 5.6
*Two of the institutions in each column of this row were academic but excluded because of either number or location.
HVAMC, High volume academic medical center; HVNAMC, high volume nonacademic medical center; LVNAMC, low volume nonaca-
demic medical center; MVNAMC, medium volume nonacademic medical center. 
significantly less in each individual year and overall
when compared with the HVNAMCs and the
MVNAMCs. The latter groups averaged nearly a full
day shorter (P = .0001). No difference existed
between these latter two sites, which averaged 1.2
and 1.4 days, respectively. No differences were seen
in comparison with the LVNAMCs, which lasted 1.1
days. Hospital LOS did not differ among the groups
in any year or overall statistically (P = .07), but hos-
pital LOS decreased at HVAMCs from FY95 to
FY97 (P = .02). Length of stay at the other centers
remained constant.
Outcomes. The mortality rates did not differ
among the groups in FY95 (P = .29) or in FY96 (P =
.29). However, in FY97 and overall, the mortality rate
was less for both types of high volume centers as com-
pared with the MVNAMCs (P = .002 and .001) but
not different among each other. The stroke rates were
less in FY95 (P = .004), FY97 (P = .005), and overall
(P = .0004) at the HVAMCs as compared with the
HVNAMCs and MVNAMCs. In FY96, there was no
difference (P = .71). Low volume non-AMCs had no
difference in all the comparisons. Finally, the combined
stroke-mortality rates were all significantly less at the
HVAMCs than at either the HVNAMCs or the
MVNAMCs in FY97 (P = .001) and overall (P =
.007), but no difference existed in FY95 (P = .20) or
in FY96 (P = .53). Specifically, the HVAMCs had a
0.90% stroke-mortality rate, the HVNAMCs had a rate
of 1.88%, and the MVNAMCs had a rate of 2.54%.
There was no significance in the difference of all the
groups with the data within the LVNAMC group.
Unfortunately, comorbidity analysis is not possi-
ble with the HealthShare database. This assumes
importance in differentiating whether better out-
comes with a procedure are related to a healthier,
lower risk patient population. However, one recog-
nized risk factor for a potential morbid outcome is
advanced age.6 We found that, per hospital, 5.17%
of all the patients aged 80 years and older in
Massachusetts undergo CEAs in HVAMCs as com-
pared with 2.22% at HVNAMCs, 1.33% at
MVNAMCs, and 0.58% at LVNAMCs.
DISCUSSION
Graduate medical education is funded through
two mechanisms from the federal government. The
first is through DME and the second is through indi-
rect medical expense (IME). Direct medical expense
was set up to address the direct costs of a teaching
program such as house staff salaries and fringe bene-
fits, faculty teaching compensation, administrative
personnel, an allocation of overhead, and a variety of
required teaching materials.14 Direct medical expense
is paid in regular lump sum intervals for an entire
institution and is based on hospital-specific base-year
direct cost per resident as determined by the govern-
ment; inflation; the number of residents at a center;
and the percentage of Medicare inpatient days over
total inpatient days. Residents who are beyond their
base training (eg, vascular fellows) are treated as a
fraction (one half) of a resident. An inflation factor is
only included for primary care residents but not for
specialists (eg, all of surgery). Direct medical expense
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Table II. Summary of yearly and overall data for each of the groupings
HVAMC HVNAMC
FY95 FY96 FY97 Overall FY95 FY96 FY97 Overall
No. of CEA 967 989 927 2883 1456 1771 1309 4536
No. of centers 5 5 5 5 19 23 18 20
No. of CEA per center 193 198 185 192 77 77 73 76
Total cost with DME $8706 $8157 $6784 $7882 $6844 $6609 $5971 $6475
Total cost without DME $7688 $7121 $5997 $6936 $6531 $6350 $5749 $6227
LOS* 3.87 3.19 2.54 3.20 4.26 3.78 3.25 3.76
ICU LOS* 0.38 0.38 0.27 0.34 1.29 1.23 1.22 1.25
No. of strokes 2 8 5 15 19 22 24 65
No. of deaths 4 6 1 11 6 10 6 22
Stroke rate 0.21% 0.81% 0.54% 0.52% 1.23% 1.24% 1.83% 1.41%
Mortality rate 0.41% 0.61% 0.11% 0.38% 0.39% 0.56% 0.46% 0.48%
Stroke-mortality rate 0.62% 1.42% 0.65% 0.90% 1.62% 1.81% 2.29% 1.88%
% of all pts age >80 per center 5.30% 4.58% 5.64% 5.17% 2.36% 2.19% 2.12% 2.22%
*LOS data is expressed in days.
CEA, Carotid endarterectomy; DME, direct medical expense; FY, fiscal year; HVAMC, high volume academic medical center; HVNAMC,
high volume nonacademic medical center; ICU, intensive care unit; LOS, length of stay; LVNAMC, low volume nonacademic medical 
center; MVNAMC, medium volume nonacademic medical center; pts, patients. 
is usually allocated through accounting mechanisms
to each surgical procedure. Therefore, most financial
reviews use total cost with DME when institutional
expenses are addressed.
On the other hand, IME is a reimbursement that
is based on the federal government’s determination
that operating costs are traditionally higher at AMCs
than at non-AMCs. This assumption is founded on
several factors: more costly staffing requirements, a
greater number of diagnostic tests ordered by resi-
dent physicians in training, and finally a greater com-
plexity and severity of illness in AMCs that is not
accounted for in the standard reimbursement by
Medicare. In contrast to the lump sum method of
DME payments, IME is a factor added to every
diagnosis-related group (DRG)/procedure reim-
bursement according to the ratio of the total num-
ber of residents to the total bed number in a given
medical center.
The BBA will have widespread impact on all hos-
pitals, but in particular on AMCs. The major adverse
effect of the BBA for an AMC resides in the reduc-
tion of IME payments. Before this change in policy
is detailed, an explanation of the components of
Medicare reimbursement for a specific procedure is
necessary. Standard (nonmanaged care) Medicare
reimbursement begins with a base rate that is multi-
plied by a relative weight (or case-mix) index to pro-
duce the baseline payment. Three factors are then
added to this baseline payment. First, IME is calcu-
lated by multiplying the given hospital’s IME rate by
the baseline payment. The second factor, the dispro-
portionate share hospital (DSH) rate, is added in
hospitals such as the NEMC, where a high propor-
tion of Medicaid patients (pediatrics and maternity)
are treated. This added incentive is calculated by
multiplying the DSH rate by the baseline payment.
Finally, capital reimbursement factors both IME and
DSH rates into a separate capital rate. These three
factors are added to the baseline payment to give
total reimbursement. The IME rate at teaching hos-
pitals in FY97 was about 7.7% for every 10 residents
to 100 beds13; the sum of the total number of resi-
dents and beds at NEMC indicates an IME rate of
50.31% of the original base payment, or $3443.58,
in FY96. The BBA decreased the IME rate to 6.5%
this year, and it will be further reduced to 5.5% in
2002. These sequential changes in reimbursement
will nearly double the reduction already realized by
AMCs. That is, the 1.2% drop in the IME rate will
be augmented to 2.2%, resulting in a change from
39.31% or $2494.38 in FY99 to 34.9% or $2186.70
in FY02. In addition, the decrease in the IME also
affects the formula for capital reimbursement. An
example of Medicare calculations for CEAs at the
NEMC in FY96 and FY99 is shown in Table III.
The decrease in IME and capital can be easily seen,
with a total reduction of nearly $2000. The predict-
ed FY 2002 reimbursement will drop further to a
total of $8950 per procedure in accordance with
current BBA guidelines.
We decided to use a bench mark vascular proce-
dure, CEA, to determine Medicare base costs and
reimbursement so that the impact of the BBA on an
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MVNAMC LVNAMC
FY95 FY96 FY97 Overall FY95 FY96 FY97 Overall
561 505 669 1735 136 130 180 446
17 13 18 16 7 7 10 8
33 39 37 36 19 19 18 19
$7393 $7194 $7066 $7218 $6002 $6153 $6563 $6239
$7124 $6647 $6867 $6898 $6000 $6035 $6417 $6184
4.53 4.04 4.17 4.25 4.51 3.57 3.59 3.89
1.36 1.36 1.42 1.38 1.18 1.07 1.13 1.13
8 4 17 29 0 1 0 1
1 0 13 14 2 1 1 4
1.43% 0.86% 2.54% 1.71% 0.00% 0.82% 0.00% 0.23%
0.18% 0.00% 1.94% 0.83% 1.47% 0.82% 0.56% 0.91%
1.60% 0.86% 4.48% 2.54% 1.47% 1.64% 0.56% 1.14%
1.10% 1.47% 1.41% 1.33% 0.72% 0.58% 0.45% 0.58%
AMC or community hospital could be modeled.
Our data analysis has demonstrated that HVAMCs
in Boston decreased their total costs with DME
from FY95 through FY97 by approximately $2000
at a time when there was no significant change in the
community hospitals’ costs for that procedure. The
consequence of this dramatic reduction was that no
cost difference existed among hospitals in the final
year of analysis. Some community programs and
AMCs have accomplished these cost reductions by
using critical pathways.11,15,16 Our data are charac-
teristic of these reductions where LOS was reduced
at AMCs by 1.33 days. In a previous study, we found
that on our vascular service, resource reduction in
radiology costs (eg, use of outpatient duplex instead
of inpatient arteriogram), in pharmacy costs (eg, use
of aspirin instead of low molecular weight dextran
and use of oral instead of intravenous vasoactive
drugs whenever possible), in ICU LOS (using stan-
dard floor-staffed step-down units), and in LOS
with active case social work involvement significant-
ly lowered total cost by nearly $3000 for CEAs over
3 years before the BBA was implemented.
Hospitals have typically used an approach that is
based on improving two efficiencies that can be
competitive. The first is technical efficiency, which is
an attempt to reduce the cost of an individual med-
ical service. The second is economic efficiency,
which tries to optimize financial return through
reimbursement relative to financial output required
to maintain services.17 This implies that reduction in
LOS or use of an ICU will only be associated with
savings when there is increased throughout in the
system. The cost for upkeep and staffing a hospital
bed is fixed, and the revenue associated with that
bed depends on more use. The cost savings to a
medical center for a DRG-based procedure in which
LOS is decreased by one or two days are minimal if
the vacated bed is not filled with another patient.
The present data show that AMCs have reached
a point at which significant cost reductions are not
feasible. Additional cost savings through efficiency
measures to maintain a profit margin are truly
impossible, and hospital cost for CEAs will no
longer decrease. In fact, hospital cost will only rise
with routine inflation typically estimated at 3% per
year. The predicted costs at HVAMCs for a CEA in
2002 will be near $8200, and Medicare reimburse-
ment, as mentioned above, will only be $8950.
When such a decreasing profit margin is faced, the
logical economic strategy is based on enhancing, if
not at the least preserving, the revenue for a specific
procedure. Our comparative analysis of CEA under-
scores the major impact of the BBA on AMCs. The
marked reduction in the projected IME component
erodes revenue. The eventual consequence for this
index procedure as well as other vascular procedures
will be a negative profit margin.
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1. DRG base rate $4332.65 $4273.17
2. x Case-mix 1.5798 1.4851
3. Payment $6844.72 $6346.08
4. IME rate 50.31% 39.31%
5. IME reimbursement (L. 3 × L. 4) $3443.58 $2494.38
6. DSH rate 15.29% 14.68%
7. DSH reimbursement (L. 3 × L. 6) $1046.46 $931.63
8. Total federal payment (L. 3 + L. 5 + L. 7) $11,334.75 $9,772.10
Capital reimbursement
9. Capital rate $529.35 $423.13
10. x Case-mix 1.5798 1.4851
11. Payment $836.27 $628.39
12. IME rate 38.47% 35.69%
13. IME reimbursement (L. 11 × L. 12) $321.70 $224.30
14. DSH rate 6.61% 6.48%
15. DSH reimbursement (L. 11 × L. 14) $21.26 $14.53
16. Total capital (L. 11 + L. 13 + L. 15) $1179.22 $867.22
17. Total DRG payment (L. 8 + L. 16) $12,513.98 $10,639.32
DRG, Diagnosis-related group; DSH, disproportionate share hospital; FY, fiscal year; IME, indirect medical expense; L, line number.
Although stroke, mortality, and stroke-mortality
rates are lowest at the HVAMC in this study, they
are quite low in all groupings. Because they include
both symptomatic and asymptomatic patients, even
the highest rates in this series are lower than the 3%
stroke-mortality guideline published by the
American Heart Association for purely asympto-
matic patients.18 The limitations of the HealthShare
Technology database do not allow us to evaluate
individual surgeon volumes, which may be an even
better predictor of outcome than hospital volume.
The reason why the LVNAMC had so few strokes
may be due to high volume surgeons operating
infrequently at low volume centers.
When overall adverse outcomes are seen in this
small a cohort, one has to look for alternative explana-
tions. First, the retrospective nature of this study relies
on the accuracy of coding to make appropriate assess-
ments of outcomes. Second, our database provides in-
hospital rates and not the standard 30-day postopera-
tive rates. Third, as LOS decreases, the in-hospital
rates may potentially drop off with adverse events
occurring outside the tracked admission. Fortunately
for the purposes of this study, mortality and stroke
associated with CEA are usually perioperative with
regard to CEA. There also is no way in a study of this
magnitude to correct potential coding errors. We have
presented a population-based study with a very large
“n” and not an institution-specific study enabling us to
show significance in a complication that occurs at a
very low rate. We assume in our analysis that the inci-
dence of coding errors accounting for the discrepan-
cies in these rates at both AMCs and non-AMCs are
the same. Therefore, we believe the outcomes are rea-
sonable for comparison among groups but are not to
be taken as comparable to the literature.
University-based medical centers have inherently
incurred costs exclusive to their academic mission,
which can be divided into GME costs, faculty-teach-
ing costs, and research. Caps have been placed on the
total number of residents in nonprimary care pro-
grams. No DME payments will be made if that num-
ber is exceeded. Many institutions have attempted to
reduce or maintain their resident count to that of this
maximum number. Many debates revolve around the
question of whether GME reimbursement is less than
GME costs, particularly when the cost of replace-
ment personnel is included. Certainly the reduction
in IME funding adversely affects the amount of fund-
ing available for administration and teaching (A & T)
of residents. As net revenues decrease at AMCs and
negative operating expenses ensue, the amount of
institutional funds available for the academic pursuits
of attending staff is closely scrutinized. The unto-
ward consequences of this chain reaction are lowered
contributions to a department such as surgery in the
form of A & T. Because academic surgeons derive
their income from clinical revenue, research pay-
ments, and A & T (the latter two are fixed), there is
a reversed incentive against academic endeavors and
toward maximizing clinical revenue. Therefore, the
academic surgeon has less of a cushion. This scenario
is further magnified by “Managed Medicare,” where
reimbursement for hospitals is characteristically at
80% of costs. The problem is further compounded by
recent cuts in professional payments. The profession-
al fee schedule is made up of work, practice (office
expenses), and malpractice (liability insurance) com-
ponents multiplied by a geographic index as well as
the resource-based relative value scale conversion fac-
tor. In FY99, the conversion factor dropped from
$36.6873 to $34.7315, and the resource-based prac-
tice expenses will decrease 3% per year over 4 years.
This 12% reduction and the Health Care Financing
Administration–projected further decreases in the
resource-based relative value scale conversion factor
when combined with decreases in A & T will direct-
ly affect surgeon income. To offset such a decline,
vascular surgeons will have to increase clinical pro-
ductivity, which may have a negative impact on their
“academic” role.
The BBA was enacted in 1997 in an effort to con-
trol deficit spending and bring the federal govern-
ment out of debt. Unfortunately, health care is one
of the areas that has been disproportionately affected.
This reduction in Medicare provider payments will
markedly reduce AMC revenue. However, HVAMCs
have the best outcomes after CEA. The overall
stroke-mortality rates in HVAMCs are half that of
HVNAMCs and one third that of MVNAMCs.
Although the cost for CEA has been reduced at
HVAMCs, it remains relatively constant at non-
AMCs. Length of stay, the driving force behind total
cost, is also decreasing. How low this can be further
pushed safely is of considerable debate. Despite the
achievement of significant efficiencies, AMCs have
only a small cushion to further reduce either LOS or
resources to maintain a competitive cost-position and
compensate for the added fixed expenses of acade-
mics. The BBA raises an equity concern for AMCs
because it differentially affects the centers with the
best outcomes. The financial implication of this may
be a direct incentive for procedures to be done in
centers with less optimal outcomes and for surgeons
to divert time from their academic endeavors into
clinical practice.
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Dr Robert M. Zwolak (Lebanon, NH). Dr Roddy, Dr
O’Donnell and coauthors are to be congratulated for
addressing the crucial topic of disappearing support for
graduate medical education (GME). The issue holds direct
importance for many people in this room, for all medical
trainees, and ultimately, for the health of all Americans.
Their study includes an analysis of surgical outcomes for all
carotid endarterectomies performed in Massachusetts dur-
ing 1995, 1996, and 1997, and it includes hospital cost
information. Their outcome and cost evaluation approach
is similar to that presented at the ISCVS two years ago by
Dr Perler and colleagues, who studied surgical outcomes
and costs in all Maryland hospitals. Today’s study goes on
to examine payments made to academic medical centers by
the Medicare program for GME. They provide us with a
description of how GME payments are calculated, and they
point out the inexorable downhill slide predicted for these
payments over the next four years. In this regard, the GME
payment reductions to hospitals parallel the depressing
reductions in Medicare payments to vascular surgeons pre-
dicted over the next 4 years. 
The authors’ data analysis suggests that surgical out-
comes are superior in high-volume academic medical cen-
ters (HVAMCs) in Massachusetts when compared with
high and medium volume nonacademic centers, but curi-
ously not when compared with low volume nonacademic
centers. Specifically, they found a lower stroke-mortality
rate in the HVAMCs. Their second observation is that
costs to perform the operation at various sites are compa-
rable despite convincingly shorter intensive care unit
length of stay (LOS) and probably shorter hospital LOS in
the HVAMCs. Finally the authors observe that GME allo-
cations will decrease disproportionately over the next 4
years, to the specific disadvantage of the major academic
centers. Their conclusion is that fiscal imperatives may
force translocation of carotid endarterectomy surgery to
hospitals with lower costs but fewer good outcomes.
As an academic vascular surgeon, I believe and fear
their conclusion may be correct. Nevertheless, I have ques-
tions about the methodology. First, the mortality results in
this study are of the best I have seen for a large population
report, 0.4% and 0.5% in the two high volume hospital
cohorts and a respectable 9.0% in low volume hospitals.
Although the NASCET and ACAS trials had remarkably
low 30-day mortalities of 0.6% and 0.1%, respectively,
recent large population clinical studies identify higher mor-
DISCUSSION
tality levels. For instance, in Maryland, Perler and col-
leagues found about twice the respective mortality rates in
high and low volume hospitals. In a report published in the
Journal of the American Medical Association last year,
David Wennberg and coauthors reviewed 30-day perioper-
ative mortality in all 113,000 Medicare patients undergo-
ing CE during 1992 and 1993. In high volume hospitals
they found a rate of 1.7%, three times more than the values
in today’s report. The Wennberg paper reported a 2.5%
mortality in low-volume hospitals, more than twice that of
the current report. In the same issue of the Journal of the
American Medical Association, Cebul and colleagues
reported a 1.8% mortality among 4000 Medicare patients
in Ohio. One might expect mortality rates to converge to
a single value as sample size increases to the very large
numbers embodied in the studies; that does not appear to
be the case. Today’s manuscript analyzes the patients by
hospital volume, but not by indication for operation,
patient comorbidity, or surgeon case volume. What are
your thoughts regarding the variable morbidity and mor-
tality rates in these large studies?
Morbidity and mortality were not captured by this
model after the patient was discharged from the hospital at
completion of the index admission, and the index LOS
was at least one half, and in some comparisons more than
a full day shorter in academic medical centers. Is it possi-
ble that the lower stroke-mortality rate identified in
HVAMCs is due to the shorter LOS? That is, were any
complications missed because they occurred after the ini-
tial discharge? The 4000 Ohio Medicare patients studied
by Cebul and coauthors had a 1.0% mortality during the
index hospitalization but a 1.8% 30-day mortality to sup-
port this possibility. Almost half of the deaths occurred
after the index discharge.
Regarding costs, estimating hospital costs from hospi-
tal charges through the use of ratio of cost to charges has
been substantially criticized as being inaccurate when com-
pared with direct accounting methods. Do the authors
have any comments to justify the use of hospital charges
and the cost-to-charge ratio as a method of cost analysis?
Regarding direct medical expense (DME) payments,
these should cover house staff salary and fringe benefits,
faculty teaching compensation, administration, and over-
head, thus all identifiable expenses of GME. As such,
DME appears to be an accounting pass-through, with
equal counterbalancing values on the expense and income
sides of the hospital ledger. This study demonstrates a sig-
nificant difference in the costs of CE between hospital
groups only when DME was included and only if all 3
years are analyzed simultaneously. Thus, it seems that real
hospital costs were similar among groups. Although costs
were similar, LOS was not. In this manuscript, the authors
describe LOS as “the major component of hospital cost.”
They then point out that patients in HVAMCs had short-
er intensive care unit LOS and possibly shorter hospital
LOS. Despite these shorter LOSs and the important con-
tribution of LOS to costs, the HVAMCs were no different
in terms of overall costs. My question is what aspects of
the hospitalization of HVAMC did drive up costs, such
that they negate the beneficial effect of shorter LOS? Is it
extra laboratory tests and extra x-ray films ordered by the
house staff? The authors do not speculate on this in the
manuscript, but they conclude that academic medical cen-
ters have reached a point at which further reductions are
not feasible.
I have several socioeconomic questions. How much
should GME payments to hospitals be? What payment
beyond actual expenses do you consider reasonable for
GME? Are there hidden costs of GME not covered by the
direct component that would further reduce this apparent
margin? Do the academic medical centers share these
funds fairly with surgeons such that would should join the
battle save them? Finally, the big picture questions. Who
should pay for GME? Will anyone pay for GME in the
next century? Should it be only Medicare, or should Blue
Cross and the giant health maintenance organizations
share the burden? The National Bipartisan Commission
on the Future of Medicare adjourned in March without
making a formal recommendation to Congress. Senator
Breaux and Representative Thomas indicated they intend
to pursue to recommendations which, for GME, include
moving DME and possibly indirect medical expense out
of the Medicare Trust Fund. Funding would continue
either through a separate mandatory entitlement or
through the appropriations process where it would con-
stitute a target for annual budget reductions. The
Medicare Payment Advisory Commission (MedPAC) is
also addressing this hot issue. I believe the MedPAC chair
is not predisposed to asking Medicare to continue paying
for GME. The only good news is that Congress has not
responded favorably to the Breaux/Thomas suggestions,
and Senators Moynihan and Kennedy introduced legisla-
tion last month that would freeze Balance Budget
Act–related cuts in Medicare indirect medical expense
payments at the 1999 levels, blocking further reductions.
The ultimate fate of this legislation is unclear at present.
Dr O’Donnell is an expert on GME funding and is active-
ly involved in trying to save it. I would like him to spec-
ulate on whether GME payments will exist 5 years from
now, and if so, who will the payer be?
Payment for GME is a crucial issue for every American
who expects to maintain the world’s best medical system.
I compliment Dr Roddy on a fine presentation, and I
thank Dr O’Donnell and coauthors for approaching this
difficult subject. I would also like to thank the program
committee for inviting me to discuss this important paper. 
Dr Thomas F. O’Donnell, Jr. In the interest of hearing
the presidential address of my good friend, Dr Zarins, I will
be terse in my response to this very enthusiastic review of
our paper, and thank Dr Zwolak for the hard work that he
has done for the Society in reimbursement after the pio-
neering work of our good friend Dr Norman Hertzer. 
The questions were related, first, to methodology.
Certainly, as Dr Roddy emphasized, these are not 30-day
statistics. They are in-hospital statistics. So the variable
that will be mostly affected, I would believe, at 30 days,
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would be the death component and not stroke, because
most strokes occur within the first 24 to 48 hours except
for intracerebral hemorrhage. So I would agree that this
does not capture deaths because of myocardial infarctions
or whatever. 
The second question is about these valid stroke rates.
We looked and compared the data derived from the state
to our own, just as Dr Perler—who was standing by a
microphone back there and just sat down—did, and they
are very similar. So we have confidence in this. And the
coders who looked through these charts and ended up
saying that there was an iatrogenic stroke, are motivated
to report everything. So I think the stroke rate is valid, but
I would agree with you that the death rate may be affect-
ed by this as just one hospital admission. 
There was a question about the ratio of cost-to-charges
methodology, which I guess raged yesterday. We would
agree with you that this is an imperfect method, but for pop-
ulation-based studies this is the only method available to us.
To that point, there are two studies, one our own, where 
we compared the ratio of cost to charges to the typical
Transition Systems, Inc, data analysis, which we actually
introduced several years ago, and they were within 5% of
each other. Then there was another paper done by Schwartz
at Boston University that compared them in a larger number
of diagnosis-related groups and found that they were within
4% of each other. So it is imperfect, but it is pretty good. 
Finally, why are things so costly in an academic med-
ical center? Well, I think this paper sort of turns it around.
It said, look, the academic medical centers have respond-
ed. They have pushed lengths of stay down. They have
minimized resource utilization through better practices.
And we are now at the point where nothing further can be
reduced without affecting our patients. We cannot do
drive-by carotids. 
As far as reimbursement and GME, is everybody pay-
ing their fair share? No, they are not. Only Medicare is. It
should be very reasonable that health maintenance organi-
zations and other insurance plans reimburse for education.
I am going up to Capitol Hill tomorrow to meet with our
own senator, Senator Kennedy, and also Senator Moynihan
will be there, to argue to stop and freeze, as their bill has
proposed, the reduction in indirect medical expense. A
great solution for the use of the tobacco funds in some
states where it is available is perhaps for GME reimburse-
ment. It is an idea. 
What happens is that GME is a big catch basket. Yes,
it is to pay you to teach residents, but it is also to take care
of faculty who take care of people who do not pay.
Hospitals get reimbursed, they have a disproportionate
share, but surgeons do not. And so we need a solution to
compensate the surgeon. 
I thank, again, Dr Zwolak, and I think we should get
to the President. Thank you.
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